Table 3.
Clinical findings
| Parameter | Colonized | Noncolonized | p value |
|---|---|---|---|
| Patients (n, %) | 59 (6.2) | 895 (93.8) | |
| BCLC stage | |||
| 0 (n, %) | 0 (0) | 2 (0.2) | 0.001 |
| A (n, %) | 15 (25.4) | 275 (30.7) | 0.001 |
| B (n, %) | 23 (39) | 390 (43.6) | 0.001 |
| C (n, %) | 9 (15.3) | 160 (17.9) | 0.001 |
| D (n, %) | 11 (18.6) | 42 (4.7) | 0.001 |
| Cirrhosis (n, %) | 56 (94.9) | 819 (91.5) | 1.0 |
| Child–Pugh score | |||
| A (n, %) | 19 (32.2) | 469 (52.4) | < 0.001 |
| B (n, %) | 22 (37.3) | 161 (18) | < 0.001 |
| C (n, %) | 11 (18.6) | 22 (2.5) | < 0.001 |
| MELD (median, range) | 14 (6–40) | 10 (6–40) | < 0.001 |
| ALBI | |||
| Grade 1 (n, %) | 9 (15.3) | 257 (28.7) | < 0.001 |
| Grade 2 (n, %) | 21 (35.6) | 331 (37) | < 0.001 |
| Grade 3 (n, %) | 19 (32.2) | 77 (8.6) | < 0.001 |
| Metastasis (n, %) | 4 (6.8) | 41 (4.6) | 0.353 |
| Treatment | |||
| Resection (n, %) | 12 (20.3) | 218 (24.4) | 0.534 |
| Local ablation (n, %) | 11 (18.6) | 189 (21.1) | 0.743 |
| Sorafenib (n, %) | 2 (3.4) | 217 (24.2) | < 0.001 |
| Liver transplantation (n, %) | 5 (8.5) | 88 (9.8) | 1.0 |
All p values reported are two-sided
Statistical significance was defined as p ≤ 0.05